Mammography Workstation Market – By Modality, By Application, By End Use – Global Forecast, 2025 – 2034

Mammography Workstation Market Size

The global mammography workstation market was valued at USD 113.6 million in 2024 and is projected to grow from USD 121.9 million in 2025 to USD 245.7 million by 2034, expanding at a CAGR of 8.1%. This steady growth is driven by the rising prevalence of breast cancer and the widespread adoption of digital mammography systems.

The inclusion of advanced imaging technologies, including 3D tomosynthesis and AI-powered CAD tools, is improving diagnostic accuracy as well as workflow efficiency. In addition to this, investments are growing in healthcare, and governments of different countries are also supporting screening programs. These factors are positively influencing the market expansion across both developed and emerging regions. A mammography workstation is a specialized medical imaging platform designed to assist radiologists in the interpretation and analysis of breast images. Major companies in the industry include GE Healthcare, Siemens Healthineers, Hologic, and Philips.
 

The market increased from USD 92.6 million in 2021 to USD 106.1 million in 2023. This growth can be primarily attributed to the rising number of breast cancer cases and the rising awareness among people for early detection. The adoption of digital and AI-powered mammography workstations surged, supported by government screening programs and technological advancements. Furthermore, healthcare system is shifting towards patient-centric diagnostics, which has made digital mammography systems the preferred choice, enhancing comfort and reducing dependency on hospital-based imaging.
 

The surge in breast cancer prevalence is one of the key factors aiding in the growth of the mammography workstation industry, as early detection is critical for improving outcomes. For instance, in 2022 alone, 2.3 million women were diagnosed with breast cancer, and 670,000 lost their lives globally. Such numbers show the urgent need for advanced diagnostic tools. Mammography workstations, especially those equipped with digital and AI capabilities, are increasingly adopted by hospitals and other end users all over the world to improve their screening capabilities.
 

Additionally, there has been an increase in the geriatric population base worldwide. This is also a significant factor supporting the growth of the mammography workstation market. According to the World Health Organization (WHO), the number of people above 60 years of age globally is projected to reach 1.4 billion by 2030 from 1.1 billion in 2023. These statistics show that regular screening is essential, as older people are more prone to developing cancer. Further, the demand for advanced mammography workstations that are user-friendly is expected to rise in the near future, as healthcare systems are trying to meet the needs of older adults.
 

Mammography workstations are a part of a modern breast imaging center's workflow. They are specialized computer systems designed for the analysis of digital mammography images. They have advanced software tools and provide high-resolution displays, which help to enhance image detail and aid doctors in detecting abnormalities. These workstations are essential for soft-copy reading, which allows for magnification, contrast adjustment, and image processing.
 

Mammography Workstation Market Trends

• The worldwide market is changing at a fast pace, influenced by macro as well as micro-level trends. At the macro level, growing government-funded screening programs are propelling demand for sophisticated diagnostic platforms. Multimodal imaging, which includes 2D, 3D tomosynthesis, ultrasound, and MRI, is becoming the standard, facilitating radiologists to produce more precise and timely diagnoses.
   
• Workstations powered by AI, featuring computer-aided detection (CAD), automated reporting, and real-time analytics, are improving diagnostic accuracy and workflow productivity. For example, Hologic's SecurView 12.0 combines Genius AI Detection 2.0 and provides multimodality imaging such as breast ultrasound and tomosynthesis.
   
• Moreover, customizable interfaces, high-resolution monitors, and integration with PACS and Electronic Health Record (EHR), which is expected to reach 64.5 billion by 2032, are the areas where the manufacturers are focused. Graphical patient history timelines, automatic breast tissue alignment, and contrast enhancement support are becoming the major differentiators. Portable and self-contained workstations are also changing outpatient and clinic-based diagnostics, providing flexibility and cost-effectiveness.
   
• Furthermore, players in this industry are investing their money into modern designs, automated features, and AI-based quality inspection to satisfy increasing demand from the end users. With healthcare systems emphasizing early detection and digitization, mammography workstations are transforming into intelligent diagnostic hubs that enable personal care, remote collaboration, and scalable deployment across various clinical environments.
   

Mammography Workstation Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

The global market was valued at USD 92.6 million in 2021. The market size reached USD 106.1 million in 2023, from USD 99 million in 2022.
 

Based on the modality, the market is segmented into multimodal and standalone. The multimodal workstation segment led this market in 2024, accounting for the highest market share because of its ability to support various imaging formats and advanced diagnostic tools. This segment was valued at USD 66.2 million in 2024 and is projected to reach USD 141.2 million by 2034, growing at a CAGR of 7.9%.
 

This growth is because of the increasing demand for integrated imaging solutions, AI-powered diagnostics, and comprehensive breast cancer screening programs across hospitals and diagnostic centers. In comparison, the standalone workstation segment, valued at USD 47.3 million in 2024, is expected to grow to USD 104.5 million by 2034, with a slightly higher CAGR of 8.3%, supported by its affordability and suitability for smaller facilities.
 

• Multimodal workstations can combine multiple imaging modalities such as tomosynthesis, digital mammography, ultrasound, and MRI. Therefore, they hold a dominant share in this market. Furthermore, these systems provide doctors with a comprehensive view of breast tissue, enhancing diagnostic accuracy and supporting complex case evaluations.
   
• A major driver for this segment is its capability to streamline workflow and improve clinical decision-making. These workstations further enable side-by-side image comparisons, seamless integration with PACS and EMR systems, and AI-assisted detection, which significantly reduces the time required interpretation, and the efficiency of reporting is also improved.
   
• For instance, GE HealthCare’s IDI Mammography Workflow Solution is a multimodal workstation that helps in showing improvement in performance through seamless RIS/MIS/PACS connectivity and automatic pre-fetching of prior exams.
   
• It also supports images from multiple modalities, including FFDM, CR, DR, MR, and ultrasound, and features auto-alignment, auto-scaling, and vendor-neutral image comparison capabilities. Overall, the multimodal workstation segment is poised to remain the cornerstone of innovation and efficiency in breast imaging diagnostics.
   

Based on the application, the mammography workstation market is segmented into diagnosis screening, advance imaging, clinical review, and hair samples. The diagnosis screening segment accounted for the highest market share of 40.2% in 2024.
 

• Diagnosis screening workstations are tailored for high-throughput settings and come with features such as automated image enhancement, artificial intelligence-driven lesion detection, and smooth integration with screening workflows.
   
• Diagnostic screening products provide simplified interfaces, fast image processing, and integration with national screening schemes, and hence are well-suited for public health programs and hospitals. Their capacity to process high quantities of patient data without much manual input maximizes efficiency and minimizes diagnostic delay.
   
• Conversely, the advance imaging segment is expected to expand to the highest CAGR of 8.6%. These workstations enable complex imaging modes such as tomosynthesis, contrast-enhanced mammography, and MRI, providing radiologists with greater insights into tissue properties and pathology.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the mammography workstation market is segmented into hospitals, specialty clinics, and other end users. The hospitals segment accounted for the highest market share of 47.8% in 2024.
 

• The hospital segment held the largest market share due to the common use of high-end imaging infrastructure and the presence of trained radiologists. Hospitals are the chief institutions for breast cancer screening, diagnosis, and treatment, thus having the largest users of multimodal and AI-based mammography workstations.
   
• This segment observes large patient volumes, state-sponsored screening programs, and integrated healthcare networks, which favor the use of advanced diagnostic imaging equipment. Further, workstations in hospitals are usually integrated with PACS, RIS, and EMR systems that allow for effortless exchange of information and effective clinical workflows.
   
• Additionally, the specialty clinics segment, accounting for 29.5% market share in 2024, is expanding quickly with the growth of dedicated breast imaging centers and outpatient diagnostic facilities. The clinics favor small, freestanding workstations that provide affordability, simplicity, and quick turnaround, making them well-suited for focused diagnostic services.
   

Looking for region specific data?

Download Free PDF

North America dominated the global mammography workstation market with the highest market share of 50.4% in 2024. The region has advanced healthcare infrastructure, and the rate of adoption of innovative medical technologies is also high. Further, there is an increasing prevalence of breast cancer in the U.S. and Canada, thus propelling the growth of this market.
 

• The U.S. market was valued at 84 million and USD 89.7 million in 2021 and 2022, respectively. In 2024 the market size reached USD 102.8 million from USD 96.1 million in 2023.
   
• The country observed a surge in the number of cancer patients over the years. According to the American Cancer Society, over 287,000 new invasive breast cancer cases were diagnosed in 2022, with more than 51,000 cases of ductal carcinoma in situ.
   
• Similarly, according to the data from the Global Cancer Observatory, in 2022, approximately 89.1% of cancer cases in North America were from the U.S. Such statistics underscore the country’s high burden of oncological diseases.
   
• Moreover, the process of regulatory approvals is regularized in developed countries such as the U.S., and the country also has high public awareness and robust R&D investment, which support the continuous rollout of innovative imaging solutions.
   
• Thus, as there is growing demand for cloud-based diagnostics, remote collaboration, as well as workflow automation, the market is expected to see sustained revenue growth through 2030, driven by both public health initiatives and private sector innovation.
   

Europe mammography workstation market accounted for USD 27.3 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Europe’s market is driven by its strategic adoption of digital breast imaging technologies and AI-integrated diagnostic platforms. The region has a rising prevalence of breast cancer and also has observed the implementation of national screening programs. According to the European Commission, over 355,000 women in the EU-27 were diagnosed with breast cancer in 2021, accounting for 13.3% of all cancer diagnoses.
   
• Germany, France, and the UK are leading countries in adopting advanced mammography workstations. These countries are integrating multimodal workstations that support 2D, 3D tomosynthesis, and CAD overlays, enhancing diagnostic accuracy and workflow efficiency. Public-private partnerships and mobile screening initiatives are further accelerating market growth.
   

Germany mammography workstation market is projected to experience steady growth between 2025 and 2034.
 

• The market in Germany is expanding steadily, driven by rising breast cancer incidence and strong healthcare infrastructure. For instance, according to Statista, in 2022, breast cancer had the highest incidence rate among females, at 148 per 100,000 population, according to Statista.
   
• Such statistics show that there is a requirement for accelerating demand for advanced imaging solutions that support 2D, 3D tomosynthesis, and AI-powered diagnostics. Further, hospitals and screening centers are increasingly adopting multimodal workstations to enhance workflow efficiency and diagnostic accuracy.
   

The Asia Pacific region is projected to be valued at USD 22.2 million in 2025 and is expected to reach USD 47.3 million by 2034.

• The region is expected to grow at the fastest CAGR because of the surge in awareness about breast cancer, expanding government-sponsored screening programs, and increasing disposable incomes. Furthermore, the region’s growing elderly population and improving insurance coverage boost demand.
   
• In Asia Pacific, the number of older persons is projected to increase from 630 million in 2020 to about 1.3 billion by 2050. By 2050, one quarter of the population will be 60 or older.
   

Japan mammography workstation market is poised to witness lucrative growth between 2025 – 2034.
 

• The country’s aging demographic is a major driver, with 29.1% of the population aged 65 and older as of 2023, according to Statista. This trend is increasing demand for early detection and preventive care, boosting adoption of digital and AI-powered mammography systems.
   
• Government initiatives and public awareness campaigns are expanding access to screening services, positioning Japan as a key player in the Asia-Pacific imaging landscape.
   

Brazil is experiencing significant growth in the mammography workstation market, driven by its expanding adoption of chronic disease management.
 

• In Brazil, breast cancer was the most frequently diagnosed cancer among women in 2020. According to the Global Cancer Observatory, an estimated 66,280 new cases were reported throughout the year, representing 29.7% of all cancer types and an incidence rate of 43.7 per 100,000 women. This growing burden is accelerating demand for non-invasive diagnostic solutions, including advanced mammography workstations that support 2D, 3D tomosynthesis, and AI-powered imaging.
   
• Additionally, Brazil’s aging population is contributing to increased screening needs. As per the Brazilian Institute of Geography and Statistics, the number of individuals aged 65 and older reached 22.17 million in 2022, accounting for 10.9% of the total population, a 57.4% increase since 2010. This demographic shift is driving adoption of digital and cloud-based workstations, particularly in public hospitals and regional screening programs, positioning Brazil as a key emerging market in Latin America for mammography technology.
   

The mammography workstation market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia's elderly population is rising at a much faster pace than any other segment. It is estimated that the population aged 60 years and above will grow from 2 million (5.9 percent of the total population) in 2020 to 10.5 million by 2050. This population shift will lead to greater requirements for mammography workstations as older people are more prone to cancer.
   

Mammography Workstation Market Share

• The top 5 players, such as GE Healthcare, Hologic, Siemens Healthineers, Fujifilm, and Philips Healthcare, collectively held 65% of the total market share. These firms retain their leadership through a mix of technological advancements, AI incorporation, regulatory clearance, and strategic collaborations with healthcare organizations.
   
• Hologic is the leading player with its SecurView DX Workstation, which is designed to optimize 2D and 3D mammography and collaborate easily with its tomosynthesis systems. The advantage of this system lies in its efficiency, real-time collaboration tools, and CAD integration, making it a preferred option for high-volume breast imaging centers.
   
• Meanwhile, new competitors such as Sectra, Agfa-Gevaert, and Carestream Health are making headway with low-cost, AI-enabled, and cloud-capable solutions. These players are filling gaps in the market for telemammography, low-resource environments, and image-enabled interoperable platforms.
   
• To increase market share, firms are introducing cost-effective multimodal workstations and CAD options enabled by artificial intelligence for dense breast tissue examination and 3D tomosynthesis interpretation. Advances in high-resolution display, automatic quality control, and real-time analytics are also transforming the competitive market.
   

Mammography Workstation Market Companies

Few of the prominent players operating in the mammography workstation industry include:

• Agfa-Gevaert Group
• Analogic
• aycan Medical Systems
• Carestream Health
• EIZO
• Fujifilm
• GE Healthcare
• Hologic
• Konica Minolta Business Solutions India
• Medecom
• Metaltronica 
• Phillips Healthcare
• Sectra
• Siemens Healthineers
   
• Agfa-Gevaert Group

Agfa stands out with its Enterprise Imaging Platform, which is designed to transform healthcare delivery. It allows seamless access to patient images across various specialties, making it easier for healthcare providers to collaborate. The SmartXR portfolio uses AI-driven predictive assistance to streamline radiographic workflows, enhancing both diagnostic accuracy and operational efficiency. The company’s ability to combine imaging technology with IT solutions provides scalable platforms that support teamwork and informed decision-making in healthcare.
 

• EIZO

EIZO makes high-precision medical-grade monitors, which are a key component in diagnostic imaging, such as mammography and radiology. The RadiForce series stands out with DICOM Part 14 compliance, onboard calibration sensors, and uniformity correction to guarantee uniform image quality. EIZO's dedication to providing clear and dependable visuals enables healthcare professionals to diagnose correctly and minimizes the likelihood of misinterpretation in clinical environments.
 

• Sectra

Sectra’s mammography workstations focuses on vendor-neutral enterprise imaging solutions that unify radiology, pathology, and cardiology imaging onto one platform. These systems are geared for smooth interoperability, allowing for simple integration with hospital IT systems. With a strong focus on cybersecurity, scalability, and clinical collaboration, Sectra has emerged as the choice of large healthcare networks looking to streamline image management and enhance patient care.
 

Mammography Workstation Industry News:

• In June 2024, FUJIFILM India Healthcare Division and NM Medical Mumbai launched the first Fujifilm skill lab. It was launched for full-field digital mammography, and the partnership is expected to equip medical professionals with skills that can revolutionize mammography practice.
   
• In April 2024, Hologic collaborated with Bayer to deliver contrast-enhanced mammography (CEM) solutions. The MEDRAD Stellant FLEX CT Injection System with Certegra Workstation was the first computed tomography injection system 510(k) approved with an additional contrast-enhanced mammography (CEM) application.
   

The mammography workstation market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Modality

• Multimodal
• Standalone

Market, By Application

• Diagnosis screening
• Advance imaging
• Clinical review
• Hair samples

Market, By End Use

• Hospitals
• Specialty clinics
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE